Joseph B. Elmes

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Levine Cancer Institute(Current)

Atrium Medical Cente

Joseph B. Elmes is an author at Levine Cancer Institute specializing in immunopathology, immune-related adverse events, and checkpoint inhibitor therapy.

Publications per year

2022–2024

Publications

PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review

Donald C. Moore, Joseph B. Elmes, Justin Arnall et al. · International Immunopharmacology · 2024 · 37 citations

Medicine, Hematology, Pharmacology +16

Acquired thrombotic thrombocytopenic purpura associated with immune checkpoint inhibitors: A real-world study of the FDA adverse event reporting system

Donald C. Moore, Joseph B. Elmes, Justin Arnall et al. · International Immunopharmacology · 2022 · 21 citations

Life Sciences, Hematology, Immunology +17

Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis

Donald C. Moore, Joseph B. Elmes, Justin Arnall et al. · International Journal of Clinical Pharmacy · 2023 · 10 citations

Life Sciences, Immunology, Pharmacology +17

1–3 of 3